Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 mars 2019 08h00 HE | Source: Rubius Therapeutics

Rubius Therapeutics Announces FDA Clearance of Investigational New Drug Application for First-Ever Red Cell Therapeutic, RTX-134, for Treatment of Phenylketonuria

CAMBRIDGE, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely...
11 mars 2019 08h00 HE | Source: Attis Industries, Inc.

Attis Industries Increases Size of Board Through New Appointments

Adds Two New Board Members with Capital Markets, Public Sector Industry Experience MILTON, GA, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Attis Industries, Inc.(NASDAQ: ATIS)...
11 mars 2019 08h00 HE | Source: Victory Capital Holdings, Inc.

Victory Capital Ranks 9th in Barron’s 2018 Best Fund Families

Firm’s Highest Ever RankingEarns 4th Place in Mixed Asset Category and 5th in Taxable Bond Category CLEVELAND, March 11, 2019 (GLOBE NEWSWIRE) -- Victory Capital (NASDAQ:VCTR) today announced...
11 mars 2019 08h00 HE | Source: BioXcel Therapeutics, Inc.

BioXcel Therapeutics Announces Late Breaking Data Presentation at AACR 2019 Annual Meeting

NEW HAVEN, Conn., March 11, 2019 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq: BTAI) today announced that it will present a late breaking poster featuring data from a preclinical...
11 mars 2019 08h00 HE | Source: Eidos Therapeutics, Inc.

Eidos Therapeutics to Present at 31st Annual ROTH Conference

SAN FRANCISCO, March 11, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced that management is scheduled to participate in a fireside chat regarding Eidos at the...
11 mars 2019 08h00 HE | Source: LexaGene Holdings Inc

LexaGene’s CEO Invited by USDA to Present a Seminar on the Benefits of Adopting Rapid Genetic Testing to Improve Food Safety

BEVERLY, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for pathogen detection...
11 mars 2019 08h00 HE | Source: Gritstone Oncology, Inc

Gritstone Oncology Announces the Appointment of Technology Executive, Mike Forcht, as Senior Vice President of Human Resources to Support Vision for Growth

EMERYVILLE, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to...
11 mars 2019 08h00 HE | Source: Principia Biopharma Inc.

Principia Biopharma Reacquires Rights to Oral Immunoproteasome Program

-- Principia and AbbVie mutually agree to end collaboration ---- Preclinical stage program focused on development of oral immunoproteasome inhibitors to treat inflammation and autoimmune disorders -- ...
11 mars 2019 08h00 HE | Source: FXCM Group

FXCM Group Reports Monthly Execution Data

LONDON and SYDNEY, Australia and JOHANNESBURG, South Africa, March 11, 2019 (GLOBE NEWSWIRE) -- FXCM Group, LLC ("FXCM Group" or “FXCM”), a leading international provider of online foreign exchange...
11 mars 2019 08h00 HE | Source: Dare Bioscience, Inc.

Daré Bioscience receives notification of second award from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development for the development of Ovaprene®

SAN DIEGO, March 11, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that it received a second Notice of Award of $982,851, part...

Page précédente

Page suivante